← All trials
NCT03367910
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 8, 2018
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Dec 11, 2017
- Last posted
- Mar 18, 2022
- Enrollment
- 1
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Washington University in St. LouisLead sponsor
- Rebiotix Inc.Collaborator
- University of PennsylvaniaCollaborator
- Duke UniversityCollaborator
- Rush UniversityCollaborator
- Washington University in St. LouisOverall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.